Table 2.
Patient No. | Last normal to puncture | Puncture to reperfusion | General anesthesia | Intraprocedural antithrombotics | Extracranial intervention | Intracranial intervention |
---|---|---|---|---|---|---|
1 | 3.3 h | 2.8 h | no | heparin 4,500 U, abciximab 4 mg (IV) | pre-angioplasty and stent | retriever, 1 pass |
2 | progressive | 2.5 h | yes | heparin 5,500 U, abciximab 6 mg (IV) | intracranial angioplasty | intracranial angioplasty |
3 | 7.2 h | 1.2 h | no | heparin 1,000 U, abciximab 5 mg (IV) | pre-angioplasty | retriever, 1 pass |
4 | 10.0 h | 1.5 h | no | heparin 4,000 U, abciximab 18 mg (IV) | none | retriever, 2 passes |
5 | 4.6 h | N/A | yes | heparin 5,000 U | thromboaspiration | none |